Aspirin: Should it be used for primary prevention in diabetics?

Press/Media: Research


Dundee, UK - A new study has found no evidence that aspirin or antioxidants are of any benefit in the primary prevention of cardiovascular events in diabetic patients with asymptomatic peripheral arterial disease (PAD) [1]Dr Jill Belch (University of Dundee, Scotland) and colleagues report the findings from the P revention and P rogression of A rterial D isease and D iabetes(POPADAD) trial online October 16, 2008 in BMJ.

Period17 Oct 2008

Media coverage


Media coverage